Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Hodgkin Disease 1

Interventions

Cyclophosphamide 6 pembrolizumab 5 fludarabine phosphate 5 Vinblastine 5 Nivolumab 5 Granulocyte Colony-Stimulating Factor 5 Filgrastim 5 Doxorubicin 5 Dacarbazine 5 fludarabine 4 Whole-Body Irradiation 4 Mycophenolic Acid 4 Melphalan 4 Magnetic Resonance Spectroscopy 4 Brentuximab Vedotin 4 pegfilgrastim 3 Etoposide 3 Cyclosporine 3 Busulfan 3 Tacrolimus 2 Radiotherapy 2 Peripheral Blood Stem Cell Transplantation 2 Fluorodeoxyglucose F18 2 Azacitidine 2 treosulfan 1 tocilizumab 1 thymoglobulin 1 tafasitamab 1 selinexor 1 polatuzumab vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hodgkin Disease × Bleomycin × 30 days × Clear all

NCT04685616 2026-06-02

RADAR

University College, London

Phase 3 Recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡